title: Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease.
authors.forename: Rainer H
authors.initials: RH
authors.lastname: Boger
authors.forename: Jan
authors.initials: J
authors.lastname: Frystyk
authors.forename: Thomas
authors.initials: T
authors.lastname: Ledet
authors.forename: Niels
authors.initials: N
authors.lastname: Moller
authors.forename: Allan
authors.initials: A
authors.lastname: Flyvbjerg
authors.forename: Hans
authors.initials: H
authors.lastname: Orskov
mesh_terms: D015984:Causality; D015897:Comorbidity; D003327:Coronary Disease / Q000097:blood* / Q000453:epidemiology; D004730:Endothelium, Vascular / Q000187:drug effects / Q000378:metabolism / Q000502:physiology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006801:Humans; D015994:Incidence; D018972:Insulin-Like Growth Factor Binding Protein 3 / Q000097:blood / Q000378:metabolism; D007334:Insulin-Like Growth Factor I / Q000172:deficiency / Q000378:metabolism* / Q000494:pharmacology; D017202:Myocardial Ischemia / Q000097:blood* / Q000453:epidemiology; D009569:Nitric Oxide / Q000378:metabolism; D012306:Risk; D014664:Vasodilation / Q000187:drug effects / Q000502:physiology; D019323:omega-N-Methylarginine / Q000494:pharmacology
chemical_list: D004791:Enzyme Inhibitors; D018972:Insulin-Like Growth Factor Binding Protein 3; D019323:omega-N-Methylarginine; D009569:Nitric Oxide; D007334:Insulin-Like Growth Factor I